Agilent Technologies Inc
NYSE:A
Relative Value
The Relative Value of one A stock under the Base Case scenario is 166.55 USD. Compared to the current market price of 132.44 USD, Agilent Technologies Inc is Undervalued by 20%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
A Competitors Multiples
Agilent Technologies Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Agilent Technologies Inc
NYSE:A
|
38.8B USD | 5.8 | 31.4 | 25.1 | 30.2 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
209.4B USD | 4.9 | 34.9 | 21.7 | 31.8 | ||
US |
Danaher Corp
NYSE:DHR
|
174.7B USD | 7.3 | 36.8 | 24.9 | 35.2 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.2B USD | 2.8 | 30.4 | 16.5 | 25.6 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.4T KRW | 15 | 64.6 | 34.1 | 49.1 | ||
CH |
Lonza Group AG
SIX:LONN
|
36.8B CHF | 5.5 | 56.3 | 19.3 | 28.4 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
27.7B USD | 9.4 | 46.7 | 32 | 38.2 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
25.7B USD | 6.8 | 32.5 | 22.8 | 25.4 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
24.1B USD | 3 | 39.3 | 16.8 | 26.2 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.3B EUR | 7 | 62.4 | 32.2 | 48.5 | ||
US |
Illumina Inc
NASDAQ:ILMN
|
18.6B USD | 4.1 | -16 | 53.3 | -249.9 |